Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents

A paper titled “Analysis of Strategy for Extending Patent Protection of Rucaparib” by Zhifeng Wang. discusses the strategies employed by pharmaceutical companies to extend the patent protection period of the drug Rucaparib. Rucaparib is a medication used in the treatment of ovarian cancer and is subject to various patent strategies. The article highlights several key […] Source